CD8 + T cells within the tumor, which are reinvigorated and expanded following DB1 therapy. Interleukin-10 (IL-10) plays a ...

Targeted B cell elimination (INB-619) highlights potential applications in B cell–driven autoimmune diseases as well as cancer ...